| [1] |
Croce CM. Oncogenes and cancer[J]. N Engl J Med, 2008, 358(5): 50 2-11.
|
| [2] |
Stein LD. Human genome: end of the beginning[J]. Nature, 2004, 43 1(7011): 915-6.
|
| [3] |
Pennisi E. Human genome. A low number wins the GeneSweep Pool[J]. Science, 2003, 300(5625): 1484.
|
| [4] |
Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution[J]. Science, 2005, 30 8(5725): 1149-54.
|
| [5] |
Mattick JS, Makunin IV. Non-coding RNA[J]. Hum Mol Genet, 20 06, 15 Spec No 1: R17-29.
|
| [6] |
Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease[J]. J Pathol, 2010, 220 (2): 126-39.
|
| [7] |
Will CL, Luhrmann R, Cech R, et al. The RNA World[M].3rd edition. Long island, New York, USA. Cold Spring Harbor Laboratory Press, 2006: 369-400.
|
| [8] |
Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer[J]. Biochim Biophys Acta, 2012, 1826(1): 121-8.
|
| [9] |
Gardner PP, Bateman A, Poole AM. SnoPatrol: how many snoRNAs genes are there?[J]. J Biol, 2010, 9(1): 4.
|
| [10] |
Terns MP, Terns RM. Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin[J]. Gene Expr, 2002, 10 (1-2) : 17-39.
|
| [11] |
Smith CM, Steitz JA. Sno storm in the nucleolus: new roles for myriad small RNPs [J]. Cell, 1997, 89(5): 669-72.
|
| [12] |
Bortolin ML, Kiss T. Human U19 intron-encoded snoRNAs is processed from a long primary transcript that possesses little potential for protein coding[J]. RNA, 1998, 4(4): 445-54.
|
| [13] |
Zhang YC, Zhou H, Qu LH. Structure and function of snoRNAs[J]. Sheng Ming Ke Xue, 2008, 20(2): 171-7.[ 张筱晨, 周惠, 屈良鹄. snoRNA的结构与功能[J]. 生命科学, 2008, 20(2): 171-7.]
|
| [14] |
Chang LS, Lin SY, Lieu AS, et al. Differential expression of human 5S snoRNAs genes[J]. Biochem Biophys Res Commun, 20 02, 299(2): 196-200.
|
| [15] |
Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C[J]. Science, 2006, 311(5758): 23 0-2.
|
| [16] |
Dong XY, Rodriguez C, Guo P, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer[J]. Hum Mol Genet, 2008, 17 (7): 1031-42.
|
| [17] |
Dong XY, Guo P, Boyd J, et al. Implication of snoRNAs U50 in human breast cancer [J]. J Genet Genomics, 2009, 36(8): 447-54.
|
| [18] |
Pacilli A, Ceccarelli C,Treré D, et al. SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription[J]. Int J Mol Sci, 2013, 14(7): 14923-35.
|
| [19] |
Mei YP, Liao JP, Shen J, et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis[J]. Oncogene, 2012, 31(22): 27 94-804.
|
| [20] |
Liao J, Yu L, Mei Y, et al. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer[J]. Mol Cancer, 2010, 9: 198.
|
| [21] |
Donsante A, Miller DG, Li Y, et al. AAV vector integration sites in mouse hepatocellular carcinoma[J]. Science, 2007, 317(5837): 477.
|
| [22] |
Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis[J]. Int J Cancer, 2011, 129(4): 77 3-9.
|
| [23] |
Ko JM, Yau WL, Chan PL, et al. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumorsuppressive regions to 14q32[J]. Genes Chromosomes Cancer, 20 05, 43 (3): 284-93.
|
| [24] |
Feng J, Funk WD, Wang S, et al. The RNA component of human telomerase[J]. Science, 1995, 269(5228): 1236-41.
|
| [25] |
Trahan C, Dragon F. Dyskeratosis congenita mutations in the H/ ACA domain of human telomerase RNA affect its assembly into a pre-RNP[J]. RNA, 2009, 15(2): 235-43.
|
| [26] |
Sieron P, Hader C, Hatina J, et al. DKC1 overexpression associated with prostate cancer progression[J]. Br J Cancer, 2009, 10 1(8): 1410-6.
|
| [27] |
Montanaro L, Bigotti M, Clohessy J, et al. Dyskerin expression in?uences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer[J]. J Pathol, 20 06, 210(1): 10-8.
|
| [28] |
Cui Z, DiMario PJ. RNAi knockdown of Nopp 140 induces Minute-like phenotypes in Drosophila[J]. Mol Biol Cell, 2007, 18 (6): 2179-91.
|
| [29] |
Isaac C, Marsh KL, Paznekas WA, et al. Characterization of the nucleoli gene product, treacle, in Treacher Collins syndrome [J]. Mol Biol Cell, 2000, 11(9): 3061-71.
|
| [30] |
Su H, Xu T, Ganapathy S, et al. Elevated snoRNA biogenesis is essential in breast cancer[J]. Oncogene, 2014, 33(11): 1348-58.
|
| [31] |
Nallar SC, Kalvakolanu DV. Regulation of snoRNAs in cancer: close encounters with interferon[J]. J Interferon Cytokine Res, 20 13, 33(4): 189-98.
|
| [32] |
Nakamoto K, Ito A, Watabe K, et al. Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function [J]. Am J Pathol, 2001, 159 (4): 1363-74.
|
| [33] |
Michel CI, Holley CL, Scruggs BS, et al. Small nucleolar RNAs U32a, U33 and U35a are critical mediators of metabolic stress [J]. Cell Metab, 2011, 14 (1): 33-44.
|
| [34] |
Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer[J]. Oncogene, 2009, 28(2): 195-208.
|
| [35] |
Williams GT,Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer?[J]. Nat Rev Cancer, 2012, 12(2): 84-8.
|
| [36] |
Askarian-Amiri ME, Crawford J, French JD, et al. SNORDhost RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer[J]. RNA, 2011, 17(5): 878-91.
|
| [37] |
Gee HE, Buffa FM, Camps C, et al. The small-nucleolar RNAs commonly used for microRNA normalization correlate with tumor pathology and prognosis[J]. Br J Cancer, 2011, 104(7): 1168-77.
|
下载:
